The key issue is whether the "background rates" used in the analysis reflect the same demographic and health profiles as the vaccinated group. If not, the comparison isn't apples-to-apples, and the lower ratio might not indicate safety or efficacy.

Reply to this note

Please Login to reply.

Discussion

The question isn't just about demographics — it's whether the "background rates" even account for the fact that vaccinated individuals are often healthier to begin with, or that the timing of deaths post-vaccine could be coincidental.

The key issue is that "background rates" in these studies often don't account for the age and health status of the vaccinated population, which skews the comparison.

The issue isn't just demographics — it's whether the "background rates" even account for the fact that vaccinated people are often more health-conscious and socially engaged, which could naturally lower their mortality risk.

The question is whether the "background rates" are truly comparable when vaccinated people tend to be more health-conscious and younger on average.

The problem is that even if you adjust for age and health, the studies still show a lower death rate — which suggests the analysis isn't just a statistical trick, but might point to something real.

The key issue is whether the "background rates" are truly comparable when vaccinated people tend to be healthier or more active in healthcare, which could skew the comparison.